Quaker Chemical (KWR) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
3 Nov, 2025Executive summary
Q2 2025 net sales rose 4% year-over-year to $483.4 million, driven by 2% organic volume growth, acquisitions, and strong Asia/Pacific and specialty products performance, but offset by lower selling prices and product mix.
Reported net loss of $66.6 million includes an $88.8 million non-cash goodwill impairment in EMEA; non-GAAP net income was $30.0 million ($1.71 per diluted share).
Adjusted EBITDA was $75.5 million (15.6% margin), down from $84.3 million (18.2%) a year ago, with gross margin at 36%.
All segments delivered sequential organic volume growth, with Asia/Pacific leading year-over-year sales growth; Americas and EMEA faced volume and margin pressures.
Continued focus on customer-centric strategy, cost reduction, and operational efficiency, with share repurchases of $32.7 million and a 5% dividend increase.
Financial highlights
Q2 2025 net sales: $483.4 million (+4% YoY); adjusted EBITDA: $75.5 million (15.6% margin); non-GAAP EPS: $1.71; GAAP net loss: $66.6 million ($(3.78) per share) due to goodwill impairment.
Gross margin was 36% (non-GAAP), down from 37.9% in Q2 2024, reflecting higher raw material and manufacturing costs.
Operating cash flow was $42 million for Q2 and $38.5 million for H1 2025, down from $73.5 million in H1 2024.
Net debt at June 30, 2025: $734.8 million; total gross debt: $936.7 million; cash and equivalents: $201.9 million.
Share repurchases totaled $32.7 million in Q2 2025; quarterly dividend increased by 5%.
Outlook and guidance
Economic and end market softness expected to persist through H2 2025, with full-year revenue and earnings anticipated to be in the range of 2024.
Cost-saving actions target $20 million in run-rate savings by end of 2026; additional restructuring expected to generate at least $35 million in annualized savings.
Management expects sufficient liquidity and compliance with credit facility terms.
Full-year effective tax rate expected between 28% and 29%.
Second half expected to be stronger than first half, with Q3 typically the strongest quarter.
Latest events from Quaker Chemical
- Q4 2025 delivered higher sales and EBITDA, led by Asia-Pacific growth and acquisitions.KWR
Q4 202524 Feb 2026 - Growth, margin recovery, and targeted M&A drive resilience in a fragmented global market.KWR
Gabelli Funds' 16th Annual Specialty Chemicals Symposium3 Feb 2026 - Net income and margins rose in Q2 2024 despite lower sales, with further growth expected.KWR
Q2 20242 Feb 2026 - Q3 2024 sales fell 6% as Americas and EMEA softened, but Asia/Pacific grew and margins held firm.KWR
Q3 202417 Jan 2026 - Q1 2025 sales and earnings declined, but liquidity and acquisitions support a stable outlook.KWR
Q1 202523 Dec 2025 - Q4 2024 saw lower sales and earnings, but cash flow and acquisitions support 2025 growth.KWR
Q4 202419 Dec 2025 - Virtual annual meeting to vote on directors, executive pay, auditor, and sustainability oversight.KWR
Proxy Filing1 Dec 2025 - Q3 2025 sales rose 7% with strong Asia-Pacific growth and higher adjusted EBITDA and EPS.KWR
Q3 20252 Nov 2025